0001805035-21-000001.txt : 20210121 0001805035-21-000001.hdr.sgml : 20210121 20210121114642 ACCESSION NUMBER: 0001805035-21-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20210121 DATE AS OF CHANGE: 20210121 EFFECTIVENESS DATE: 20210121 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Amunix Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001805035 IRS NUMBER: 271108708 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-386939 FILM NUMBER: 21541004 BUSINESS ADDRESS: STREET 1: 2 TOWER PL, #1100 CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080-1826 BUSINESS PHONE: 650-428-1800 MAIL ADDRESS: STREET 1: 2 TOWER PL, #1100 CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080-1826 D 1 primary_doc.xml X0708 D LIVE 0001805035 Amunix Pharmaceuticals, Inc. 2 TOWER PL, #1100 SOUTH SAN FRANCISCO CA CALIFORNIA 94080-1826 650-428-1800 DELAWARE None None Corporation true Angie You c/o Amunix Pharmaceuticals, Inc. 2 Tower Place, #1100 South San Francisco CA CALIFORNIA 94080 Executive Officer Director Volker Schellenberger c/o Amunix Pharmaceuticals, Inc. 2 Tower Place, #1100 South San Francisco CA CALIFORNIA 94080 Executive Officer James Brush c/o Amunix Pharmaceuticals, Inc. 2 Tower Place, #1100 South San Francisco CA CALIFORNIA 94080 Director Richard Heyman c/o Amunix Pharmaceuticals, Inc. 2 Tower Place, #1100 South San Francisco CA CALIFORNIA 94080 Director David Hirsch c/o Amunix Pharmaceuticals, Inc. 2 Tower Place, #1100 South San Francisco CA CALIFORNIA 94080 Director Otello Stampacchia c/o Amunix Pharmaceuticals, Inc. 2 Tower Place, #1100 South San Francisco CA CALIFORNIA 94080 Director James Topper c/o Amunix Pharmaceuticals, Inc. 2 Tower Place, #1100 South San Francisco CA CALIFORNIA 94080 Director Trisha Millican c/o Amunix Pharmaceuticals, Inc. 2 Tower Place, #1100 South San Francisco CA CALIFORNIA 94080 Director Biotechnology Decline to Disclose 06b false 2021-01-07 false true true false 0 743277 0 743277 Represents securities offered under a service provider equity incentive plan. false 1 0 0 0 false Amunix Pharmaceuticals, Inc. /s/ Angie You, Ph.D. Angie You, Ph.D. CEO 2021-01-21